These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An Optimized Tat/Rev Induced Limiting Dilution Assay for the Characterization of HIV-1 Latent Reservoirs. Mishra S; Gohil Y; Mehta K; D'silva A; Amanullah A; Selvam D; Pargain N; Nala N; Sanjeeva GN; Ranga U Bio Protoc; 2022 Apr; 12(8):e4391. PubMed ID: 35800103 [TBL] [Abstract][Full Text] [Related]
6. Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay. Châtel L; Yang X; Cholette F; Soudeyns H; Sandstrom P; Lavigne C Arch Virol; 2018 Oct; 163(10):2701-2710. PubMed ID: 29882046 [TBL] [Abstract][Full Text] [Related]
7. Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1. Bertoldi A; D'Urbano V; Bon I; Verbon A; Rokx C; Boucher C; van Kampen JJA; Gruters RA; Gallinella G; Calza L; Mahmoudi T; De Crignis E; Re MC J Virol Methods; 2020 Feb; 276():113778. PubMed ID: 31756409 [TBL] [Abstract][Full Text] [Related]
8. RNA-mediated TILDA for improved cell capacity and enhanced detection of multiply-spliced HIV RNA. Pezzi HM; Berry SM; Beebe DJ; Striker R Integr Biol (Camb); 2017 Nov; 9(11):876-884. PubMed ID: 29098230 [TBL] [Abstract][Full Text] [Related]
9. Specific quantification of inducible HIV-1 reservoir by RT-LAMP. Hossain T; Lungu C; de Schrijver S; Kuali M; Crespo R; Reddy N; Ngubane A; Kan TW; Reddy K; Rao S; Palstra RJ; Madlala P; Ndung'u T; Mahmoudi T Commun Med (Lond); 2024 Jun; 4(1):123. PubMed ID: 38918506 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study. Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369 [TBL] [Abstract][Full Text] [Related]
11. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection. Frank I; Acharya A; Routhu NK; Aravantinou M; Harper JL; Maldonado S; Sole Cigoli M; Semova S; Mazel S; Paiardini M; Derby N; Byrareddy SN; Martinelli E Sci Rep; 2019 Aug; 9(1):12078. PubMed ID: 31427605 [TBL] [Abstract][Full Text] [Related]
12. [Research advances in evaluation and measurement techniques of latent human immunodeficiency virus reservoirs]. Qihui Z; Biao Z Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(3):256-60. PubMed ID: 27651189 [TBL] [Abstract][Full Text] [Related]
13. An Improved Tat/Rev Induced Limiting Dilution Assay With Enhanced Sensitivity and Breadth of Detection. Mehta K; Gohil Y; Mishra S; D'silva A; Amanullah A; Selvam D; Pargain N; Nala N; Sanjeeva GN; Ranga U Front Immunol; 2021; 12():715644. PubMed ID: 34421920 [TBL] [Abstract][Full Text] [Related]
14. TZA, a Sensitive Reporter Cell-based Assay to Accurately and Rapidly Quantify Inducible, Replication-competent Latent HIV-1 from Resting CD4 Sanyal A; Rangachar VS; Gupta P Bio Protoc; 2019 May; 9(10):. PubMed ID: 31428662 [TBL] [Abstract][Full Text] [Related]
15. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection. Dhummakupt A; Rubens JH; Anderson T; Powell L; Nonyane BA; Siems LV; Collinson-Streng A; Nilles T; Jones RB; Tepper V; Agwu A; Persaud D JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31999647 [TBL] [Abstract][Full Text] [Related]
16. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay. Stuelke EL; James KS; Kirchherr JL; Allard B; Baker C; Kuruc JD; Gay CL; Margolis DM; Archin NM Front Immunol; 2020; 11():1971. PubMed ID: 32849659 [TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A mBio; 2018 Nov; 9(6):. PubMed ID: 30425153 [TBL] [Abstract][Full Text] [Related]
18. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency. Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583 [TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents. Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644 [TBL] [Abstract][Full Text] [Related]
20. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir. Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L mBio; 2017 Aug; 8(4):. PubMed ID: 28811349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]